A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis–infected Adults

Rationale: Novel tuberculosis (TB) vaccines should be safe and effective in populations infected with Mycobacterium tuberculosis (M.tb) and/or HIV for effective TB control. Objective: To determine the safety and immunogenicity of MVA85A, a novel TB vaccine, among M.tb- and/or HIV-infected persons in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Scriba, Thomas J., Tameris, Michele, Smit, Erica, van der Merwe, Linda, Hughes, E. Jane, Kadira, Blessing, Mauff, Katya, Moyo, Sizulu, Brittain, Nathaniel, Lawrie, Alison, Mulenga, Humphrey, de Kock, Marwou, Makhethe, Lebohang, Janse van Rensburg, Esme, Gelderbloem, Sebastian, Veldsman, Ashley, Hatherill, Mark, Geldenhuys, Hendrik, Hill, Adrian V. S., Hawkridge, Anthony, Hussey, Gregory D., Hanekom, Willem A., McShane, Helen, Mahomed, Hassan
Format: Artigo
Jezik:Inglês
Izdano: American Thoracic Society 2012
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3326425/
https://ncbi.nlm.nih.gov/pubmed/22281831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201108-1548OC
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items